233 related articles for article (PubMed ID: 24530518)
21. Mechanism of an unusual, but clinically significant, digoxin-bupropion drug interaction.
He J; Yu Y; Prasad B; Chen X; Unadkat JD
Biopharm Drug Dispos; 2014 Jul; 35(5):253-63. PubMed ID: 24436229
[TBL] [Abstract][Full Text] [Related]
22. Aspirin and probenecid inhibit organic anion transporter 3-mediated renal uptake of cilostazol and probenecid induces metabolism of cilostazol in the rat.
Wang C; Wang C; Liu Q; Meng Q; Cang J; Sun H; Peng J; Ma X; Huo X; Liu K
Drug Metab Dispos; 2014 Jun; 42(6):996-1007. PubMed ID: 24692216
[TBL] [Abstract][Full Text] [Related]
23. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
[TBL] [Abstract][Full Text] [Related]
24. Dioscin enhances methotrexate absorption by down-regulating MDR1 in vitro and in vivo.
Wang L; Wang C; Peng J; Liu Q; Meng Q; Sun H; Huo X; Sun P; Yang X; Zhen Y; Liu K
Toxicol Appl Pharmacol; 2014 Jun; 277(2):146-54. PubMed ID: 24680847
[TBL] [Abstract][Full Text] [Related]
25. Enhanced systemic availability of methotrexate in the presence of morin in rats.
Hong SS; Jin MJ; Han HK
Biopharm Drug Dispos; 2008 May; 29(4):189-93. PubMed ID: 18240155
[TBL] [Abstract][Full Text] [Related]
26. Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants.
Badagnani I; Castro RA; Taylor TR; Brett CM; Huang CC; Stryke D; Kawamoto M; Johns SJ; Ferrin TE; Carlson EJ; Burchard EG; Giacomini KM
J Pharmacol Exp Ther; 2006 Aug; 318(2):521-9. PubMed ID: 16702441
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the interaction between nonsteroidal anti-inflammatory drugs and methotrexate using human organic anion transporter 3-transfected cells.
Maeda A; Tsuruoka S; Kanai Y; Endou H; Saito K; Miyamoto E; Fujimura A
Eur J Pharmacol; 2008 Oct; 596(1-3):166-72. PubMed ID: 18789319
[TBL] [Abstract][Full Text] [Related]
28. Interaction between rhein acyl glucuronide and methotrexate based on human organic anion transporters.
Yuan Y; Yang H; Kong L; Li Y; Li P; Zhang H; Ruan J
Chem Biol Interact; 2017 Nov; 277():79-84. PubMed ID: 28890383
[TBL] [Abstract][Full Text] [Related]
29. Drug interaction between celecoxib and methotrexate in organic anion transporter 3-transfected renal cells and in rats in vivo.
Maeda A; Tsuruoka S; Ushijima K; Kanai Y; Endou H; Saito K; Miyamoto E; Fujimura A
Eur J Pharmacol; 2010 Aug; 640(1-3):168-71. PubMed ID: 20478302
[TBL] [Abstract][Full Text] [Related]
30. OAT1 and OAT3: targets of drug-drug interaction between entecavir and JBP485.
Xu Q; Wang C; Meng Q; Liu Q; Sun H; Peng J; Ma X; Kaku T; Liu K
Eur J Pharm Sci; 2013 Mar; 48(4-5):650-7. PubMed ID: 23313623
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate pharmacokinetics in transgenic mice with liver-specific expression of human organic anion-transporting polypeptide 1B1 (SLCO1B1).
van de Steeg E; van der Kruijssen CM; Wagenaar E; Burggraaff JE; Mesman E; Kenworthy KE; Schinkel AH
Drug Metab Dispos; 2009 Feb; 37(2):277-81. PubMed ID: 19022939
[TBL] [Abstract][Full Text] [Related]
32. Molecular pharmacokinetic mechanism of the drug-drug interaction between genistein and repaglinide mediated by P-gp.
Jin H; Zhu Y; Wang C; Meng Q; Wu J; Sun P; Ma X; Sun H; Huo X; Liu K; Tan A
Biomed Pharmacother; 2020 May; 125():110032. PubMed ID: 32187961
[TBL] [Abstract][Full Text] [Related]
33. Effects of proton pump inhibitors and famotidine on elimination of plasma methotrexate: Evaluation of drug-drug interactions mediated by organic anion transporter 3.
Narumi K; Sato Y; Kobayashi M; Furugen A; Kasashi K; Yamada T; Teshima T; Iseki K
Biopharm Drug Dispos; 2017 Dec; 38(9):501-508. PubMed ID: 28801980
[TBL] [Abstract][Full Text] [Related]
34. Characterization of methotrexate transport and its drug interactions with human organic anion transporters.
Takeda M; Khamdang S; Narikawa S; Kimura H; Hosoyamada M; Cha SH; Sekine T; Endou H
J Pharmacol Exp Ther; 2002 Aug; 302(2):666-71. PubMed ID: 12130730
[TBL] [Abstract][Full Text] [Related]
35. Role of kidney-specific organic anion transporters in the urinary excretion of methotrexate.
Takeuchi A; Masuda S; Saito H; Doi T; Inui K
Kidney Int; 2001 Sep; 60(3):1058-68. PubMed ID: 11532100
[TBL] [Abstract][Full Text] [Related]
36. Ex vivo stimulation of renal transport of the cytostatic drugs methotrexate, cisplatin, topotecan (Hycamtin) and raltitrexed (Tomudex) by dexamethasone, T3 and EGF in intact human and rat kidney tissue and in human renal cell carcinoma.
Fleck C; Hilger R; Jurkutat S; Karge E; Merkel U; Schimske A; Schubert J
Urol Res; 2002 Sep; 30(4):256-62. PubMed ID: 12202944
[TBL] [Abstract][Full Text] [Related]
37. Interactions of human organic anion transporters with diuretics.
Hasannejad H; Takeda M; Taki K; Shin HJ; Babu E; Jutabha P; Khamdang S; Aleboyeh M; Onozato ML; Tojo A; Enomoto A; Anzai N; Narikawa S; Huang XL; Niwa T; Endou H
J Pharmacol Exp Ther; 2004 Mar; 308(3):1021-9. PubMed ID: 14610216
[TBL] [Abstract][Full Text] [Related]
38. Puerarin improves methotrexate-induced renal damage by up-regulating renal expression of Oat1 and Oat3 in vivo and in vitro.
Liu Q; Liu Z; Huo X; Wang C; Meng Q; Sun H; Sun P; Peng J; Ma X; Liu K
Biomed Pharmacother; 2018 Jul; 103():915-922. PubMed ID: 29710508
[TBL] [Abstract][Full Text] [Related]
39. Transporters as a determinant of drug clearance and tissue distribution.
Shitara Y; Horie T; Sugiyama Y
Eur J Pharm Sci; 2006 Apr; 27(5):425-46. PubMed ID: 16488580
[TBL] [Abstract][Full Text] [Related]
40. Characterization of methotrexate elimination and interaction with indomethacin and flurbiprofen in the isolated perfused rat kidney.
Statkevich P; Fournier DJ; Sweeney KR
J Pharmacol Exp Ther; 1993 Jun; 265(3):1118-24. PubMed ID: 8509997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
